CALGARY, AB and SAN DIEGO, CA--(Marketwired - January 16, 2018) - Oncolytics Biotech ® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN ® , also known as pelareorep, an intravenously delivered immuno-oncolytic virus that activates ...
more»